Brief: Sunshine Biopharma - Enters At-The-Market Sales Agreement With Aegis Capital For Up To $4 Million - SEC Filing
20/07/2026 21:46
BRIEF-Sunshine Biopharma - Enters At-The-Market Sales Agreement With Aegis Capital For Up To $4 Million - SEC Filing July 20 (Reuters) - Sunshine Biopharma Inc SBFM.O:
SUNSHINE BIOPHARMA - ENTERS AT-THE-MARKET SALES AGREEMENT WITH AEGIS CAPITAL FOR UP TO $4 MILLION - SEC FILING
Source text: [ID:n0001683168-26-005656]
Further company coverage: SBFM.O
((((Reuters.Briefs@thomsonreuters.com;));))